{
  "id": 165815,
  "name": "FRESENIUS MEDICAL CARE NORTH AMERICA",
  "slug": "fresenius-medical-care-north-america",
  "state": "DC",
  "description": "Health care company focused on renal and other chronic conditions",
  "totalSpending": 1620000,
  "filings": 29,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 200000
    },
    {
      "year": 2019,
      "income": 200000
    },
    {
      "year": 2020,
      "income": 200000
    },
    {
      "year": 2021,
      "income": 180000
    },
    {
      "year": 2022,
      "income": 240000
    },
    {
      "year": 2023,
      "income": 240000
    },
    {
      "year": 2024,
      "income": 180000
    },
    {
      "year": 2025,
      "income": 180000
    }
  ],
  "firms": [
    "AVENUE SOLUTIONS"
  ],
  "lobbyists": [
    "TRACY SPICER",
    "ELIZABETH BARNETT",
    "AMY TEJRAL",
    "JORDAN LACROSSE",
    "AIMEE LEWIS"
  ],
  "issues": [
    "HCR",
    "MMM",
    "VET",
    null
  ],
  "sampleDescriptions": [
    "Issues related to healthcare discussions/offsets for budget deal and healthcare extenders;\nH.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018;\nH.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018",
    "Bundled Payments for Care Improvement (BPCI) program;\nSNP reauthorization;\nMedicare extenders;\nS. 870, CHRONIC Care Act of 2017;\nIssues related to chronic kidney disease and ESRD;\nH.R. 3178, Medicare Part B Improvement Act of 2017;\nH.R. 4143/S. 2065, Dialysis PATIENTS Demonstration Act of 2017;\nCalcimimetics change to bundle payment",
    "H.R. 4143/S. 2065, Dialysis PATIENTS Demonstration Act of 2017",
    "Issues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); \n\nS. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);\n\nS. 2680, Opioid Crisis Response Act of 2018;",
    "VA contracting extension",
    "H.R. 4143/S. 2065, Dialysis PATIENTS Demonstration Act of 2017; \n\nVascular access reimbursement (2019 ASC Proposed Rule)",
    "Vascular access reimbursement (2019 ASC Proposed Rule); \n\nEnd-Stage Renal Disease Seamless Care Organization (ESCO) Model methodology",
    "Issues related to opioids policies and offsets;\n\nH.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); \n\nS. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018);\n\nS. 2680, Opioid Crisis Response Act of 2018",
    "Issues related to End Stage Renal Disease and Chronic Kidney Disease",
    "Vascular access reimbursement (2019 ASC Proposed Rule); \n\nEnd-Stage Renal Disease Seamless Care Organization (ESCO) Model methodology; \n\nS. 988, Improving Transparency and Accuracy in Medicare Part D Spending Act",
    "End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19);\n\nIssues related to End Stage Renal Disease and Chronic Kidney Disease;\n\nExecutive Order on Advancing American Kidney Health (July 10, 2019)",
    "H.R. 748 (Public Law 116-136), CARES Act - issues related to childcare for essential health workers",
    "Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;\n\nContinued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;\n\nContinued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;                      \n\nH.R. 6800 - HEROES Act;\n\nTelehealth issues related to COVID-19",
    "End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19);\n\nIssues related to End Stage Renal Disease and Chronic Kidney Disease;\n\nExecutive Order on Advancing American Kidney Health (July 10, 2019);\n\nMonitor Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Final Rule",
    "Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;\n\nContinued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;\n\nContinued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;                      \n\nH.R. 6800, The Heroes Act (particularly childcare provisions)\n\nH.R. 925, The Heroes Act (particularly childcare provisions)\n\nTelehealth issues related to COVID-19",
    "End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19);\n\nIssues related to End Stage Renal Disease and Chronic Kidney Disease;\n\nExecutive Order on Advancing American Kidney Health (July 10, 2019);\n\nMonitor Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Final Rule;\n\nH.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; Public Law 116-159",
    "Continued monitoring of implementation of Public Law 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020;\n\nContinued monitoring of implementation of Public Law 116-127, Families First Coronavirus Response Act;\n\nContinued monitoring of implementation of Public Law 116-136, CARES Act - proposals related to physician and provider relief;                      \n\nH.R. 6800, The Heroes Act (particularly childcare provisions)\n\nH.R. 925, The Heroes Act (particularly childcare provisions)\n\nTelehealth issues related to COVID-19;\n\nH.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)",
    "End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19);\n\nIssues related to End Stage Renal Disease and Chronic Kidney Disease;\n\nExecutive Order on Advancing American Kidney Health (July 10, 2019);\n\nMonitor Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program Final Rule;\n\nH.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act; Public Law 116-159;\n\nIssues related to evaluation and management (E&M) cuts contained in the CY2021 Medicare Physician Fee Schedule (MPFS) Proposed Rule;\n\nExtension of the Medicare Sequester",
    "Continued monitoring of implementation of Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (PL 116-123);\n\nContinued monitoring of implementation of Families First Coronavirus Response Act (PL 116-127);\n\nContinued monitoring of implementation of CARES Act (PL 116-136) - proposals related to physician and provider relief;                                                                      \n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); \n\nVaccine distribution for dialysis facilities",
    "End Stage Renal Disease (ESRD) Treatment Choices Model (ETC Model) Proposed Rule (84 FR 34478, 7/18/19); \n\nIssues related to End Stage Renal Disease and Chronic Kidney Disease; \n\nH.R.1319, American Rescue Plan Act of 2021 (PL 117-2); \n\nContinued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); \n\nExtension of the Medicare Sequester;\n\nH.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes;\n\nS. 748, Medicare Sequester Relief Act;\n\nTelehealth Expansion Act;\n\nTelehealth issues related to COVID-19; \n\nS. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -10,
  "trajectory": "stable",
  "yearsActive": 8,
  "avgAnnualSpending": 202500,
  "peakYear": 2022,
  "lobbyistCount": 5,
  "firmCount": 1,
  "issueCount": 3,
  "industry": "healthcare"
}